Claro Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-30,700
| Closed | -$187K | – | 298 |
|
2021
Q3 | $187K | Buy |
30,700
+5,850
| +24% | +$35.6K | 0.08% | 242 |
|
2021
Q2 | $205K | Buy |
24,850
+100
| +0.4% | +$825 | 0.09% | 222 |
|
2021
Q1 | $222K | Hold |
24,750
| – | – | 0.11% | 193 |
|
2020
Q4 | $286K | Hold |
24,750
| – | – | 0.15% | 158 |
|
2020
Q3 | $258K | Sell |
24,750
-400
| -2% | -$4.17K | 0.16% | 153 |
|
2020
Q2 | $331K | Buy |
25,150
+150
| +0.6% | +$1.97K | 0.23% | 123 |
|
2020
Q1 | $197K | Buy |
25,000
+2,450
| +11% | +$19.3K | 0.18% | 147 |
|
2019
Q4 | $467K | Sell |
22,550
-750
| -3% | -$15.5K | 0.36% | 85 |
|
2019
Q3 | $319K | Buy |
23,300
+1,200
| +5% | +$16.4K | 0.28% | 110 |
|
2019
Q2 | $272K | Sell |
22,100
-50
| -0.2% | -$615 | 0.25% | 122 |
|
2019
Q1 | $276K | Buy |
22,150
+5,500
| +33% | +$68.5K | 0.27% | 117 |
|
2018
Q4 | $312K | Buy |
+16,650
| New | +$312K | 0.25% | 93 |
|